ArticleCancer cell international2021

Correction to: Synergism between the phosphatidylinositol 3-kinase p110β isoform inhibitor AZD6482 and the mixed lineage kinase 3 inhibitor URMC-099 on the blockade of glioblastoma cell motility and focal adhesion formation.

Hua-Fu Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.